Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Charge Enterprises Shares Gain On Surpassing $100M In Infrastructure Backlog

Charge Enterprises, Inc (NASDAQ:CRGE) reported a $107 million signed infrastructure project backlog as of March 31, 2023. The company had reported…
byAkanksha Bakshi
April 19, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Charge Enterprises, Inc (NASDAQ:CRGE) reported a $107 million signed infrastructure project backlog as of March 31, 2023.
  • The company had reported 4Q22 infrastructure segment backlog of $82 million.
  • The growth was driven by significant growth in CRGE’s EV infrastructure division. EV charging infrastructure backlog represents over 20% of the total backlog.
  • The company reaffirmed its commitment to pursuing growth within the EV charging infrastructure sector.
  • “The growth of our EV charging infrastructure division, Charge Infrastructure (CI), reinforces our strategy to focus on the EV transition as a pillar of our company’s future. CI’s backlog growth, now representing over 20% of the total, supports that our unique and specialized offering is valued by our clients,” commented Andrew Fox, CEO of Charge.
  • Price Action: CRGE shares are trading higher by 3.67% at $1.13 premarket on the last check Wednesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cholesterol Player NewAmsterdam Pharma’s Obicetrapib Is A Potential Blockbuster In Cardiovascular Market: Bullish Analyst Says

By Vandana Singh
January 16, 3:48 PM
Piper Sandler's coverage on NewAmsterdam Pharma and its clinical-stage therapy, Obicetrapib, a potent CETP inhibitor targeting cardiovascular health. With a unique mechanism, superior efficacy, and market potential, Piper gives an Overweight rating and a $37 price target.

NAMS